Literature DB >> 6688119

Relationship of cellular folate cofactor pools to the activity of 5-fluorouracil.

M B Yin, S F Zakrzewski, M T Hakala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6688119

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN： 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  16 in total

1.  Inhibition of thymidylate synthase by the diastereoisomers of leucovorin.

Authors:  P P Lee; R L Schilsky
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Pharmacokinetics of (-)-folinic acid after oral and intravenous administration of the racemate.

Authors:  P O Greiner; J Zittoun; J Marquet; J M Cheron
Journal:  Br J Clin Pharmacol       Date:  1989-09       Impact factor: 4.335

3.  Folinic acid modulation of fluorouracil: tissue kinetics of bolus administration.

Authors:  C P Spears; B G Gustavsson; R Frösing
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

4.  Phase I study of phosphonacetyl-L-aspartate, 5-fluorouracil, and leucovorin in patients with advanced cancer.

Authors:  A Hageboutros; A Rogatko; E M Newman; C McAleer; J Brennan; F P LaCreta; G R Hudes; R F Ozols; P J O'Dwyer
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

5.  Comparative cytotoxicity of folate-based inhibitors of thymidylate synthase and 5-fluorouracil +/- leucovorin in MGH-U1 cells.

Authors:  C Erlichman; B Mitrovski
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  Effect of methotrexate on intracellular folate pools in purified myeloid precursor cells from normal human bone marrow.

Authors:  J Baram; C J Allegra; R L Fine; B A Chabner
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

7.  Double modulation of 5-fluorouracil by high-dose leucovorin and interferon alpha 2b in advanced colorectal cancer: a phase I and a phase II study of weekly administration.

Authors:  G G Steger; R M Mader; M P Djavanmard; M F Gnant; G Locker; C Marosi; H Rainer; R Jakesz
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

8.  Phase II trial of 5-fluorouracil and folinic acid in the treatment of advanced breast cancer.

Authors:  S Fine; C Erlichman; L Kaizer; D Warr; T Gadalla
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Lack of enhanced cytotoxicity of cultured L1210 cells using folinic acid in combination with sequential methotrexate and fluorouracil.

Authors:  L L Danhauser; R Heimer; E Cadman
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

10.  Phase II trial of 5-fluorouracil, high-dose leucovorin calcium, and dipyridamole in advanced prostate cancer.

Authors:  D Singh; J H Doroshow; L Leong; K Margolin; S Akman; J Raschko; G Somlo; R Morgan; J Harrison; J Cho
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.